Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 209,819 | 172,879 | 144,962 | 162,186 | 140,670 |
| Receivables | 214,562 | 184,614 | 183,897 | 206,876 | 237,140 |
| Inventories | 201,175 | 205,447 | 203,188 | 189,446 | 191,083 |
| Other current assets | 62,494 | 74,492 | 77,460 | 49,792 | 58,347 |
| TOTAL | $688,050 | $637,432 | $609,507 | $608,300 | $627,240 |
| Non-Current Assets | |||||
| PPE Net | 232,990 | 234,383 | 240,334 | 245,719 | 251,977 |
| Intangibles | 1,296,874 | 1,315,551 | 1,329,019 | 1,346,534 | 1,412,311 |
| Other Non-Current Assets | 332,687 | 335,333 | 347,288 | 357,315 | 352,731 |
| TOTAL | $1,862,551 | $1,885,267 | $1,916,641 | $1,949,568 | $2,017,019 |
| Total Assets | $2,550,601 | $2,522,699 | $2,526,148 | $2,557,868 | $2,644,259 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,490 | 26,269 | 30,157 | 25,311 | 31,644 |
| Accrued Expenses | 72,111 | 65,363 | 62,778 | 91,454 | 85,801 |
| Other current liabilities | 40,525 | 32,608 | 34,991 | 34,216 | 34,082 |
| TOTAL | $153,278 | $140,426 | $144,545 | $175,849 | $169,204 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 260,000 | 300,000 | 346,000 | 330,000 |
| Other Non-Current Liabilities | 97,809 | 100,263 | 104,516 | 111,042 | 95,106 |
| TOTAL | $312,019 | $371,284 | $415,789 | $463,211 | $457,030 |
| Total Liabilities | $465,297 | $511,710 | $560,334 | $639,060 | $626,234 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,569 | 156,453 | 155,813 | 155,550 | 156,767 |
| Common Shares | 1,565 | 1,559 | 1,557 | 1,550 | 1,568 |
| Retained earnings | 1,145,192 | 1,106,819 | 1,082,534 | 1,066,049 | 1,196,385 |
| Other shareholders' equity | -66,856 | -62,344 | -64,395 | -59,880 | -82,052 |
| TOTAL | $2,085,304 | $2,010,989 | $1,965,814 | $1,918,808 | $2,018,025 |
| Total Liabilities And Equity | $2,550,601 | $2,522,699 | $2,526,148 | $2,557,868 | $2,644,259 |